spacer
home > epc > spring 2017 > getting interactive
PUBLICATIONS
European Pharmaceutical Contractor

Getting Interactive

The pharmaceutical market is booming, evidenced by revenue numbers which exceeded the $1 trillion milestone in 2015, as noted in the International Trade Commission’s 2016 Top Markets Report on Pharmaceuticals (1). A good portion of that is invested in research, so there are a lot of promising developments happening in the clinical trial space. Despite these advancements, however, many industry investments in research are wasted due to problems with clinical supply management.

To get to the heart of the issue, 200 studies that wrapped up over the past two years have recently been reviewed. Out of them, 62% of the material packaged and released was not even used – two thirds of supplies never actually made it to a patient, meaning there was unnecessary spending.

Assessing the Costs

What makes up the costs associated with clinical supplies? One of the biggest considerations is drug expenses, which includes everything from production to packaging and storage. For these factors, there are fixed and variable costs that must be closely examined – for example, if a trial has 1,000 patients getting three kits each, 3,000 kits must be produced. It is also important to create an overage as it is impossible to know where those patients are going to be at all times. Buffers are also necessary and it is vital to ensure that sites do not run out of drugs.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Stefan Dürr has been working with interactive response technologies for 12 years and is currently Senior Director of Project Management at Cenduit. He is responsible for global project management and support services groups at the company with teams in India, Japan, Switzerland and the US. Stefan holds a Master’s of Science in Molecular Biology and is passionate about finding innovative solutions for clinical supply challenges.
spacer
Stefan Dürr
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MAH pilot forecast to provide further opportunities for international pharma at CPhI China


More info >>

White Papers

Running Better Trials Taking an Intelligent Monitoring Approach

Bioclinica

When it comes to implementing a risk-based monitoring program, it is not just about reducing monitoring visits and doing less Source Document Verification (SDV). It’s about bringing together your people, a solid process, and the right technology to run a better trial. Success with risk-based monitoring requires the ability to make sense of the thousands, if not millions, of data points captured by multiple disparate sources in a clinical trial. With the sheer volume of data generated on a daily basis comes complexity. How does one make sense of it all? Information overload burdens even the most experienced study teams who struggle to understand which data matters most and what it means.
More info >>

 
Industry Events

Clinical Trial Supply Logistics & Temperature Management Forum

22-24 May 2017, Hotel Del Coronado| San Diego, CA

Ensuring timely distribution and formulating key forecasting methods to avoid clinical trial disruptions. We have gathered the sharpest minds from Eli Lilly, Sunovion Pharmaceuticals, Anthera, Genentech, and many more to optimize inventory processes, package and labeling, multi-vendor management, and new forecasting ideas that demonstrate safety, efficacy, and dosage in your clinical trial supply chain at the: Clinical Trial Supply Logistics & Temperature Management Forum
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement